Chinese Traditional and Herbal Drugs
|
2025, 56(2): 536-545
Procyanidins B2-mediated LKB1/AMPK axis in regulating glycolytic metabolic pathways in treatment of obese polycystic ovary syndrome
Full
LIU Henglian1, FENG Qian1, QIAO Shicong1, ZHANG Yan1, XIA Min1
Affiliations
1 Department of Gynecology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing 400021, China
doi: 10.7501/j.issn.0253-2670.2025.02.017
Outline
Objective To investigate the specific mechanism of procyanidins B2 (PCB2) in treating obesity-related polycystic ovary syndrome (PCOS). Methods An obesity-induced PCOS rat model was established and treated with different doses of PCB2. Hematoxylin-eosin (HE) staining was used to observe the morphology of the ovarian tissue, enzyme linked immunosorbent assay (ELISA) was used to detect hormone level, actic acid and pyruvic acid levels and adenosine triphosphate (ATP) content, immunohistochemistry (IHC) was used to detect proliferating cell nuclear antigen (PCNA), cystein-asparate protease-3 (Caspase-3), liver kinase B1 (LKB1) and adenosine 5'-monophosphate-activated protein kinase (AMPK) protein expression and Western blotting (WB) was used to detect apoptotic markers, key rate-limiting enzymes of glucose metabolism, and LKB1/AMPK pathway-related proteins.Results Compared with the control group, the model group showed increased follicular atresia, increased cystic follicles, thinner granular cell layers, and fewer corpora lutea, decreased follicle-stimulating hormone (FSH) and estradiol (E2) (P < 0.01), increased luteinising hormone (LH), testosterone (T), and increased LH/FSH (P < 0.01), decreased lactic acid (LD) and adenosine triphosphate (ATP) (P<0.001), increased pyruvic acid (P < 0.001), downregulated PCNA, AMPK, and LKB1 expression (P < 0.01), and upregulated Caspase-3 expression (P < 0.01), decreased B-cell lymphoma-2 (Bcl-2) protein expression (P < 0.01) and increased Bcl-2-associated X protein(Bax) expression (P < 0.01), significantly decreased lactate dehydrogenase (LDHA) and pyruvate kinase isozyme type M2 (PKM2), and LKB1, AMPKα, and phosphorylated-AMPKα (p-AMPKα) protein expression (P < 0.01). Compared with the model group, all doses of PCB2 reversed these changes and alleviated the severity of PCOS (P < 0.05, 0.01, 0.001). Conclusion PCB2 may treat obesity-related PCOS by regulating the glycolytic metabolic pathway through the LKB1/AMPK axis.
procyanidins B2
/
obesity-related polycystic ovary syndrome
/
glycolysis
/
LKB1/AMPK axis
/
energy metabolism
刘恒炼, 冯倩, 乔世聪, 张艳, 夏敏.
原花青素B2介导LKB1/AMPK轴调控糖酵解代谢途径治疗肥胖型多囊卵巢综合征.
中草药,
2025
, 56
(2)
: 536
-545
.
DOI: 10.7501/j.issn.0253-2670.2025.02.017
LIU Henglian, FENG Qian, QIAO Shicong, ZHANG Yan, XIA Min.
Procyanidins B2-mediated LKB1/AMPK axis in regulating glycolytic metabolic pathways in treatment of obese polycystic ovary syndrome[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(2)
: 536
-545
.
DOI: 10.7501/j.issn.0253-2670.2025.02.017
Year 2025 volume 56 Issue 2
45
8
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.02.017
- Receive Date:2024-10-27
- Online Date:2026-11-13